Resources
About Us
Home Report
Store
Sequencing Kits Market
Sequencing Kits Market Size, Share, Forecast, & Trends Analysis by Type (Nucleic Acid Extraction & Amplification, Library Preparation) Technology (NGS, Sanger) Application (Drug Discovery, Oncology, Reproductive Health) End User – Global Forecast to 2031
Report ID:MRHC - 104973 Pages: 258 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Sequencing Kits Market was valued at $8.09 billion in 2023. This market is expected to reach $25.29 billion by 2031, from an estimated $9.23 billion in 2024, at a CAGR of 15.5% during the forecast period 2024-2031.
Sequencing Kits Market Size & Forecast
The growth of the sequencing kits market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications.
Moreover, government support for large-scale genomic sequencing projects, the increasing applications of genome sequencing in disease diagnostics and precision medicine, emerging economies, and advancements in genomics & proteomics are expected to generate growth opportunities for market stakeholders.
Sequencing Kits Market Growth Drivers
Increasing Applications of Genome Sequencing in Disease Diagnostics and Precision Medicine
Personalized/precision medicine uses an individual’s genomic information to offer targeted treatment. The synthesis of genes can rapidly sequence large sections of a person’s genome and aid in the formulation of precision medicine, generating cost-effective alternatives for existing therapies and allowing for novel treatments in multiple areas, including infectious diseases, drug discovery, and reproductive health, among others. Personalized medicine analyzes molecules, individual genes, and networks and translates them into an overall output for the systems of the human body.
Furthermore, with the utilization of sequencing technologies in precision medicine, cancer treatment and diagnosis are also advancing significantly. New targeted cancer treatments that use genomic data to provide patient-specific treatments are known as precision oncology, a rapidly developing field that has already become a part of mainstream clinical practices. It involves the molecular profiling of cancer cells to identify targetable alterations, also known as biomarkers. Quick and reliable sequencing of multiple genes at once is possible with sequencing. Thus, the increasing inclination toward personalized medicine-based diagnosis and treatment is expected to create opportunities for market growth.
Click here to: Get Free Sample Pages of this Report
Decreasing Costs of Sequencing Procedures
Sequencing is the process of determining the nucleic acid sequence in a DNA or RNA sample. The advent of advanced sequencing technologies such as NGS, nanopore, and single-molecule real-time (SMRT) sequencing has accelerated biological and medical research and discovery, allowing biologists and medical scientists to collect massive amounts of DNA sequence data rapidly and cost-effectively. In the past few years, the availability of advanced sequencing technologies has lowered sequencing costs and significantly reduced the time required for genome sequencing. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome decreased from USD 29,092 in 2010 to USD 562 in 2021, significantly increasing the adoption of sequencing kits & reagents.
Sequencing Kits Market Opportunity
Emerging Economies
Emerging economies in Asia-Pacific and Latin America are expected to offer market growth opportunities due to the rising demand for sequencing instruments, increasing funding for R&D, rising healthcare expenditures, and ongoing developments in healthcare infrastructure. Countries such as China, India, Brazil, and Mexico have significantly contributed to revenue generation for various stakeholders in this market, mainly due to the increasing number of research institutes, clinical and diagnostic laboratories, and pharmaceutical and biopharmaceutical companies. Additionally, growth in public and private R&D funding and contract research supports market growth in these countries.
According to the United Nations, Asia-Pacific is witnessing rapid growth in its aging population. In 2022, 12.7% of the population in Eastern and Southeastern Asia was aged 65 years or older, and the percentage is projected to increase to 25.7% by 2050. Thus, the prevalence of age-related disorders, such as cancer, is rising in Asia-Pacific.
In 2020, Latin America & the Caribbean registered 1.5 million new cancer cases, estimated to reach 1.9 million in 2030, an increase of around 31%. These numbers are expected to increase further, reaching 2.1 million and 2.4 million in 2035 and 2040, respectively. In addition, the number of deaths due to cancer is increasing in the region. This increasing cancer prevalence has significantly boosted the demand for targeted medicine in the region, which is expected to generate growth opportunities for the players in the sequencing kits market.
Increasing Applications of Genome Sequencing in Disease Diagnostics and Precision Medicine
The utilization of sequencing technologies is also growing in precision medicine. Advancements in sequencing technologies are changing how doctors diagnose and treat cancer. New targeted cancer treatments that use genomic data to provide patient-specific treatments are known as precision oncology, a rapidly developing field that has already become a part of mainstream clinical practices.
Furthermore, it involves the molecular profiling of cancer cells to identify targetable alterations, also known as biomarkers. Quick and reliable simultaneous sequencing of multiple genes has become possible with the availability of sequencing technologies such as NGS, Sanger, and nanopore.
Sequencing Kits Market Analysis: Key Findings
By Type: In 2024, the Nucleic Acid Extraction & Amplification Kits & Reagents Segment is Expected to Dominate the Sequencing Kits Market
Based on the type, the sequencing kits market is segmented into sequencing kits & reagents, library preparation kits & reagents, nucleic acid extraction & amplification kits & reagents, control kits & reagents, and other kits & reagents. In 2024, nucleic acid extraction & amplification kits segments is expected to account for the largest share of 33.0% of the sequencing kits market. The large market share of this segment is attributed to the growing adoption of sequencing-based research and development by various end users, such as pharmaceutical & biopharmaceutical companies and academic & research institutes. Also, the increasing applications of sequencing in reproductive health, oncology, agriculture, and animal research have triggered the demand for nucleic acid extraction & amplification kits & reagents.
Furthermore, the sequencing kits & reagents segment is projected to witness the highest growth rate of 16.9% during the forecast period of 2024–2031. This is due to the increasing genome sequencing activities and increasing pharmaceutical research and development.
Based on Technology: In 2024, the Next-Generation Sequencing (NGS) Segment is Expected to Dominate the sequencing kits market
Based on the type, the sequencing kits market is segmented into next-generation sequencing, Sanger sequencing, third and fourth-generation sequencing, and other sequencing technologies. In 2024, Next-Generation Sequencing (NGS) segments is expected to account for the largest share of 78.2% the sequencing kits market. The large market share of this segment is attributed to the benefits offered by NGS, such as high-throughput production, efficient instrument runs, and cost-effectiveness compared to traditional first-generation sequencing methods. Additionally, NGS is highly preferred for large-scale genomic profiling and transcriptomic sequencing.
Based on Application: In 2024, the Research Applications Segment is Expected to Dominate the sequencing kits market
Based on the application, the sequencing kits market is segmented into research applications and clinical applications. In 2024, research applications segments is expected to account for the largest share of the sequencing kits market. The largest share of this segment is attributed to the decreasing cost of sequencing procedures, the rising research and development efforts by pharmaceutical and biopharmaceutical companies in drug and biomarker discovery, the high sensitivity and throughput offered by advanced sequencing technologies, and the expanding applications of sequencing in various clinical and research areas.
Based on End User: In 2024, the Pharmaceutical & Biotechnology Companies is Expected to Dominate the sequencing kits market
Based on the end user, the sequencing kits market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users. In 2024, pharmaceutical & biotechnology segments is expected to account for the largest share of the sequencing kits market. The large market share of this segment is attributed to the declining costs of sequencing, the increase in research and development activities by pharmaceutical and biotechnology companies, and the extensive utilization of advanced sequencing products for cancer studies.
Geographical Analysis
North America to Dominate the Sequencing Kits Market
In 2024, North America is expected to account for the largest share of 50.8% of the sequencing kits market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s significant market share can be attributed to several key factors, increasing R&D expenditure by the pharmaceutical & biotechnology industry, the presence of leading sequencing kits & reagents market players in the region, favorable government initiatives for genomics research, growing applications of sequencing for diagnostic purposes in genetic diseases, oncology, and several other chronic conditions, rising awareness of NGS-based sequencing, increasing demand for precision medicine and favorable reimbursement scenario for DNA sequencing in the region.
Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 17.3% during the forecast period. The growth of this regional market is attributed to the accelerated economic growth in many countries across the region, which has increased the focus of governments in these countries on improving the healthcare sector. These government initiatives have led to increased investment to enhance the accessibility of healthcare services, healthcare infrastructure improvements, and biomarker discovery programs. The other key factors supporting the market's growth across this region include the rising prevalence of cancer, the growing adoption of advanced diagnostic and therapeutic technologies, and government initiatives to support genome sequencing programs.
Sequencing Kits Market: Key Companies
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players between 2020 and 2024. The key players profiled in the sequencing kits market report are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).
Sequencing Kits Industry Overview: Latest Developments from Key Industry Players
- In July, QIAGEN launched its QIAseq Normalizer Kits, expanding its next-generation sequencing products portfolio. These kits enable convenient, cost-effective, fast DNA library preparation for high-quality results.
- In April 2023, Thermo Fisher Scientific partnered with ALPCO-GeneProof (Czech Republic) to launch their TaqPath Menu and GeneProof PCR kits. The kits will be launched in phases for bloodborne and sexually transmitted infections (STIs). Also, panels for respiratory infections, transplant and thrombotic mutations, immunocompromised infections, and vector-borne diseases will follow.
- In May 2022, Illumina launched its TruSight Oncology Comprehensive (EU) test kit that assesses multiple tumor biomarkers and genes to reveal specific molecular profiles of cancer patients.
- In September 2020, Agilent Technologies launched its SureSelect XT HS2 RNA Reagent Kit to develop NGS workflows and applications by leveraging the versatility and performance of XT HS2 chemistry. Additionally, the kit expands NGS applications of XT HS2 chemistry, allowing customers to precisely and accurately profile gene expression and detect RNA fusions using lowinput FFPE samples.
Sequencing Kits Market Research Summary
|
Particular |
Details |
|
Page No |
258 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
15.5% |
|
Market Size (Value) |
USD 25.29 billion by 2031 |
|
Segments Covered |
By Type
By Technology
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and the Middle East & Africa. |
|
Key Companies |
Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China). |
Key questions answered in the sequencing kits market report:
This study offers a detailed assessment of the cancer/tumor profiling market based on type, technology, application, and end user. This report also involves the value analysis of various segments and subsegments of the sequencing kits market at the regional and country levels.
The sequencing kits market is projected to reach $25.29 billion by 2031, at a CAGR of 15.5% during the forecast period.
The nucleic acid extraction & amplification kits & reagents segment is expected to account for the largest share of the market in 2024.
The next-generation sequencing (NGS) segment is expected to account for the largest share of the market in 2024. The large market share of this segment is attributed to the higher sensitivity of this technique to call variants, low sequencing costs compared to other sequencing technologies, and the availability of low-cost sequencers.
The research applications segment is expected to hold the largest share of the market in 2024. The large market share of this segment is attributed to the rising incidence of cancer, the growing demand for precision medicine, the increased discovery of biomarkers, and the availability of cost-effective advanced sequencing technologies like NGS and SMRT within research protocols.
The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the market in 2024. The large market share of this segment is attributed to rising research efforts in drug discovery, the growing demand for precision medicine, and the increasing number of cancer studies aimed at advancing cancer treatment.
The growth of the sequencing kits market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications.
The key players profiled in the sequencing kits market study are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).
Emerging economies such as China and India are projected to offer significant growth opportunities to the market players due to rising investments in the healthcare sector and increasing genomic projects in these countries.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Pricing Analysis
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
5. Sequencing Kits Market Assessment—By Type
5.1. Overview
5.2. Nucleic Acid Extraction & Amplification Kits & Reagents
5.3. Sequencing Kits & Reagents
5.4. Library Preparation Kits & Reagents
5.5. Control Kits & Reagents
5.6. Other Kits & Reagents
6. Sequencing Kits Market Assessment—by Technology
6.1. Overview
6.2. Next-generation Sequencing
6.3. Sanger Sequencing
6.4. Third & Fourth-generation Sequencing
6.5. Other Sequencing Technologies
7. Sequencing Kits Market Assessment—by Application
7.1. Overview
7.2. Research Applications
7.2.1. Drug Discovery
7.2.2. Agricultural & Animal Research
7.2.3. Other Research Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Other Clinical Applications
8. Sequencing Kits Market Assessment—By End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Diagnostic Laboratories
8.4. Academic & Research Institutes
8.5. Other End Users
9. Sequencing Kits Market Assessment— by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis (2022)
10.5.1. Illumina, Inc. (U.S.)
10.5.2. Thermo Fisher Scientific Inc. (U.S.)
10.5.3. Beijing Genomics Institute (BGI) (China)
10.5.4. QIAGEN N.V. (Netherlands)
10.5.5. Agilent Technologies, Inc. (U.S.)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic
Developments, and SWOT Analysis*)
11.1. Illumina, Inc.
11.2. Thermo Fisher Scientific Inc.
11.3. Beijing Genomics Institute (BGI)
11.4. QIAGEN N.V.
11.5. Agilent Technologies, Inc.
11.6. F. Hoffmann-La Roche Ltd
11.7. PerkinElmer, Inc. (Renamed as Revvity)
11.8. Pacific Biosciences of California, Inc.
11.9. Danaher Corporation
11.10. Bio-Rad Laboratories, Inc.
11.11. Oxford Nanopore Technologies Plc.
11.12. 10X Genomics, Inc.
(*Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Number of New Cancer Cases, by Type, 2020 VS. 2030
Table 2 Common Genetic Disorders: Rates of Occurrence
Table 3 Major Global Sequencing Projects
Table 4 Health Expenditure, by Country
Table 5 Sequencing Kits & Reagents Price List
Table 6 Regulatory Authorities Governing In Vitro Diagnostics, by Country/Region
Table 7 Global Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 8 Global Nucleic Acid Extraction & Amplification Kits & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Library Preparation Kits & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Control Kits & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Other Kits & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 14 Global NGS Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Sanger Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Third & Fourth-generation Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Sequencing Kits Market for Other Sequencing Technologies, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 19 Global Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 20 Global Sequencing Kits Market for Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Sequencing Kits Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Sequencing Kits Market for Agriculture & Animal Research, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Sequencing Kits Market for Other Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 25 Global Sequencing Kits Market for Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Sequencing Kits Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Sequencing Kits Market for Reproductive Health, by Country/Region, 2022–2031 (USD Million)
Table 28 HIV Prevalence Among Adults, by Region (2020 VS. 2021)
Table 29 Global Sequencing Kits Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Sequencing Kits Market for Other Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 32 Global Sequencing Kits Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Sequencing Kits Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Sequencing Kits Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Sequencing Kits Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 37 North America: Sequencing Kits Market, by Country, 2022–2031 (USD Million)
Table 38 North America: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 39 North America: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 40 North America: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 41 North America: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 42 North America: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 43 North America: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 44 U.S.: Key Macroindicators & Microindicators
Table 45 U.S.: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 46 U.S.: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 47 U.S.: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 48 U.S.: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 49 U.S.: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 50 U.S.: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 51 Canada: Key Macroindicators & Microindicators
Table 52 Canada: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 53 Canada: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 54 Canada: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 55 Canada: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 56 Canada: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 57 Canada: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 58 Europe: Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 59 Europe: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 60 Europe: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 61 Europe: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 62 Europe: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 63 Europe: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 64 Europe: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 65 Germany: Key Macroindicators & Microindicators
Table 66 Germany: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 67 Germany: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 68 Germany: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 69 Germany: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 70 Germany: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 71 Germany: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 72 France: Key Macroindicators & Microindicators
Table 73 France: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 74 France: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 75 France: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 76 France: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 77 France: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 78 France: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 79 U.K.: Key Macroindicators & Microindicators
Table 80 U.K.: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 81 U.K.: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 82 U.K.: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 83 U.K.: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 84 U.K.: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 85 U.K.: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 86 Italy: Key Macroindicators & Microindicators
Table 87 Italy: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 88 Italy: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 89 Italy: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 90 Italy: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 91 Italy: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 92 Italy: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 93 Spain: Key Macroindicators & Microindicators
Table 94 Spain: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 95 Spain: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 96 Spain: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 97 Spain: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 98 Spain: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 99 Spain: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 100 Estimated Number of New Cancer Cases, by Country, 2020 VS. 2030
Table 101 Rest of Europe: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 102 Rest of Europe: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 103 Rest of Europe: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 104 Rest of Europe: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 105 Rest of Europe: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 106 Rest of Europe: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 107 Asia-Pacific: Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 108 Asia–Pacific: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 109 Asia-Pacific: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 110 Asia-Pacific: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 111 Asia-Pacific: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 112 Asia-Pacific: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 113 Asia-Pacific: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 114 China: Key Macroindicators & Microindicators
Table 115 China: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 116 China: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 117 China: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 118 China: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 119 China: Sequencing Kits Market for Clinical Applications, Type, 2022–2031 (USD Million)
Table 120 China: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 121 Japan: Key Macroindicators & Microindicators
Table 122 Japan: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 123 Japan: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 124 Japan: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 125 Japan: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 126 Japan: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 127 Japan: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 128 India: Key Macroindicators & Microindicators
Table 129 India: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 130 India: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 131 India: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 132 India: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 133 India: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 134 India: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 135 Estimated Number of New Cancer Cases, by Country, 2020 VS. 2030
Table 136 Rest of Asia–Pacific: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 137 Rest of Asia–Pacific: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 138 Rest of Asia–Pacific: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 139 Rest of Asia–Pacific: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 140 Rest of Asia–Pacific: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 141 Rest of Asia–Pacific: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 142 Latin America: Sequencing Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 143 Latin America: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 144 Latin America: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 145 Latin America: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 146 Latin America: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 147 Latin America: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 148 Latin America: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 149 Brazil: Key Macroindicators & Microindicators
Table 150 Brazil: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 151 Brazil: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 152 Brazil: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 153 Brazil: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 154 Brazil: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 155 Brazil: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 156 Mexico: Key Macroindicators & Microindicators
Table 157 Mexico: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 158 Mexico: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 159 Mexico: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 160 Mexico: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 161 Mexico: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 162 Mexico: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 163 Rest of Latin America: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 164 Rest of Latin America: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 165 Rest of Latin America: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 166 Rest of Latin America: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 167 Rest of Latin America: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 168 Rest of Latin America: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 169 Middle East & Africa: Sequencing Kits Market, by Type, 2022–2031 (USD Million)
Table 170 Middle East & Africa: Sequencing Kits Market, by Technology, 2022–2031 (USD Million)
Table 171 Middle East & Africa: Sequencing Kits Market, by Application, 2022–2031 (USD Million)
Table 172 Middle East & Africa: Sequencing Kits Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 173 Middle East & Africa: Sequencing Kits Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 174 Middle East & Africa: Sequencing Kits Market, by End User, 2022–2031 (USD Million)
Table 175 Recent Developments, by Company, 2020-2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Sequencing Kits Market, by Type, 2024 VS. 2031(USD Million)
Figure 8 Global Sequencing Kits Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 9 Global Sequencing Kits Market, by Application, 2024 VS. 2031 (USD Million)
Figure 10 Global Sequencing Kits Market, by End User, 2024 VS. 2031 (USD Million)
Figure 11 Global Sequencing Kits Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 12 Global Sequencing Kits Market: Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024–2031)
Figure 13 Number of Cancer Cases, by Region, 2020
Figure 14 Genome Sequencing Costs, 2010–2021 (USD/Genome)
Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 VS. 2019 VS. 2020 (USD Million)
Figure 16 Global Pharmaceutical R&D Expenditure, 2014–2028 (USD Billion)
Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
Figure 18 USFDA Regulatory Pathways for IVD Kits
Figure 19 Eu Regulatory Pathway - IVDR 2017/746
Figure 20 China: Medical Device Classification and Premarket Requirements for IVD Products
Figure 21 Porter's Five Forces Analysis
Figure 22 Global Sequencing Kits Market, by Type, 2024 VS. 2031 (USD Million)
Figure 23 Global Sequencing Kits Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 24 Global Sequencing Kits Market, by Application, 2024 VS. 2031 (USD Million)
Figure 25 U.S.: New Molecular Entity (Nme) Approvals
Figure 26 Estimated Number of New Cancer Cases (In Million)
Figure 27 Global Sequencing Kits Market, by End User, 2024 VS. 2031 (USD Million)
Figure 28 Global Pharmaceutical R&D Spending, 2014–2026 (USD Billion)
Figure 29 Global Sequencing Kits Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 30 North America: Sequencing Kits Market Snapshot
Figure 31 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 32 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 33 Europe: Sequencing Kits Market Snapshot
Figure 34 Italy: Number of Biotechnology Firms, 2010-2021
Figure 35 Rest of Europe: Pharmaceutical R&D Expenditure, 2020
Figure 36 Asia-Pacific: Sequencing Kits Market Snapshot
Figure 37 Latin America: Sequencing Kits Market Snapshot
Figure 38 Key Growth Strategies Adopted by Leading Players, 2020– 2024
Figure 39 Sequencing Kits Market: Competitive Benchmarking by Technology
Figure 40 Sequencing Kits Market: Competitive Benchmarking, by Region
Figure 41 Competitive Dashboard: Sequencing Kits Market
Figure 42 Global Sequencing Kits Market Share Analysis, by Key Players, 2023 (%)
Figure 43 Illumina, Inc.: Financial Overview (2023)
Figure 44 Thermo Fisher Scientific Inc.: Financial Overview (2023)
Figure 45 Beijing Genomics Institute (BGI): Financial Overview (2023)
Figure 46 Qiagen N.V.: Financial Overview (2023)
Figure 47 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 48 F. Hoffmann-La Roche Ltd: Financial Overview (2023)
Figure 49 Perkinelmer, Inc.: Financial Overview (2023)
Figure 50 Pacific Biosciences of California, Inc.: Financial Overview (2023)
Figure 51 Danaher Corporation: Financial Overview (2023)
Figure 52 Bio-Rad Laboratories: Financial Overview (2023)
Figure 53 Oxford Nanopore Technologies Plc.: Financial Overview (2023)
Figure 54 10X Genomics, Inc.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Whole Genome Sequencing Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Oct-2024
DNA Sequencing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
Microarray Kits Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
